Cui Hao, Cui Jian-Xin, Zhang Ke-Cheng, Liang Wen-Quan, Li Shu-Yan, Huang Jun, Chen Lin, Wei Bo
Department of General Surgery, The First Medical Center, Chinese PLA General Hospital, Beijing, P. R. China.
Foreign Languages College, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, P. R. China.
Gastroenterol Rep (Oxf). 2022 Jun 7;10:goac023. doi: 10.1093/gastro/goac023. eCollection 2022.
Many studies have shown the operative feasibility and safety of robotic gastrectomy. Surgeons are pursuing single-port (SP) surgery to leverage the advantages of minimally invasive gastrectomy. The purpose of this study was to describe technical considerations and short-term outcomes from the first reported SP robotic total gastrectomy (RTG) using the da Vinci SP platform.
A 75-year-old patient with a body-mass index of 19.8 kg/m and clinical stage III cancer (cT3N+M0) underwent SP RTG on 22 January 2022 at the Department of General Surgery, the Chinese PLA General Hospital. All procedures were performed successfully using the da Vinci SP robotic platform.
The SP RTG was successfully performed with D2 lymphadenectomy including No. 10 lymph-nodes dissection and extracorporeal Roux-en-Y anastomosis. Except for subcutaneous emphysema, no severe adverse events occurred during the operation. According to a visual analogue scale (VAS), the subjective feeling of post-operative pain was given a VAS score of 3 of 10 on Post-Operative Day 1 (POD 1), 1 of 10 on POD 3, and 1 of 10 on POD 7. We removed the gastric tube on POD 2 and advised sipping water, a liquid diet, and a soft diet on PODs 2, 4, and 6, respectively. The patient was discharged without any complications on POD 8.
RTG is technically feasible and safe using the da Vinci SP robotic platform. To our knowledge, this is the first study using the da Vinci SP platform in RTG for advanced gastric cancer in elderly patients. To verify its superior operative outcomes, further clinical trials are needed.
许多研究已证实机器人胃癌切除术的手术可行性和安全性。外科医生正在探索单孔(SP)手术,以充分利用微创胃癌切除术的优势。本研究旨在描述首例使用达芬奇单孔平台进行的单孔机器人全胃切除术(RTG)的技术要点和短期结果。
一名75岁、体重指数为19.8kg/m²且临床分期为III期癌症(cT3N+M0)的患者于2022年1月22日在中国人民解放军总医院普通外科接受了单孔RTG手术。所有手术均使用达芬奇单孔机器人平台成功完成。
成功实施了单孔RTG手术,包括D2淋巴结清扫,其中清扫了第10组淋巴结,并进行了体外Roux-en-Y吻合术。术中除皮下气肿外,未发生严重不良事件。根据视觉模拟评分法(VAS),术后第1天(POD 1)主观疼痛感受的VAS评分为3分(满分10分),POD 3时为1分,POD 7时为1分。我们在POD 2拔除胃管,并分别在POD 2、4和6建议患者饮水、进流食和软食。患者于POD 8无并发症出院。
使用达芬奇单孔机器人平台进行RTG在技术上是可行且安全的。据我们所知,这是首例在老年晚期胃癌患者的RTG中使用达芬奇单孔平台的研究。为验证其卓越的手术效果,还需要进一步的临床试验。